- page

Scroll to explore

Scroll back top

13 January 2020

Domain at the JP Morgan Healthcare conference

17 December 2019

Domain Therapeutics and Pr Michel Bouvier (IRIC Montreal) receive the RSRI award for bioSens-All™ ...

30 September 2019

Domain Therapeutics reaches two milestones in multi-target research collaboration with Boehringer In...

11 September 2019

Domain Therapeutics invests in Ermium Therapeutics to develop first-in-class CXCR4 candidate for aut...

Domain Therapeutics appoints Xavier Leroy as chief technology officer

Domain Therapeutics strengthens its scientific advisory board with leading GPCR and disease experts

Domain Therapeutics appoints Sylvie Ryckebusch to board of directors

European Venture Capital Firm Seventure Partners renews its support to Domain Therapeutics and inves...

4 December 2018

Domain Therapeutics signs a multi-target research collaboration and license agreement with Boehringe...

Domain Therapeutics’ innovative business model gains validation through Prexton Therapeutics acqui...